Glycoprotein syntheses

Thioguanine (6-TG) also inhibits several enzymes in the de novo purine nucleotide biosynthetic pathway. Various metabolic lesions result, including inhibition of purine nucleotide interconversion decrease in intracellular levels of guanine nucleotides, which leads to inhibition of glycoprotein synthesis interference with the formation of DNA and RNA and incorporation of thiopurine nucleotides into both DNA and RNA. 6-TG has a synergistic action when used together with cytarabine in the treatment of adult acute leukemia. 

Synthesis of glycosphingolipids occurs in the endoplasmic reticului and Golgi by sequential addition of glycosyl monomers transferred fio sugar-nucleotide donors to the acceptor molecule. The mechanism similar to that used in glycoprotein synthesis (see p. 164). 

Asymmetric hydrogenation of allylic alcohols (14, 39-40).1 Mammalian dol-ichols (2) are terminal dihydropolyisoprenols which are involved in glycoprotein synthesis. They contain one terminal chiral primary allylic alcohol group. The polyprenols 3 present in plants correspond to dolichols except that they lack the terminal double bond considered to be (Z). They can be obtained by hydrogenation of 2 catalyzed by (bistrifluoroacetate)ruthenium(II) and (S)-l, which affects only the terminal double bond to provide (S)-3 in >95% ee. 

---